The Korean Pharmacists for Democratic Society (CEO Hyeong-geun Shin) criticized the full budget for the stable supply of essential national medicines and urged for additional budget allocation.

On the 9th, before the National Assembly’s Health and Welfare Committee presented and deliberated on the next year's budget and proceeded with deliberation, KPDS submitted an opinion after analyzing the 2024 budget plan.

Regarding the budget plan, KPDA said, “Regarding the development and support of the pharmaceutical and bio industry, the R&D budget has been expanded significantly, including the existing Research-Focused Hospital Development Project (approximately KRW 60.5 billion), the Nation